Taxotere

Taxotere is a pharmaceutical intended for treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastic adenocarcinoma and head and neck cancer. Typically used in accompaniment with other medications, the drug is usually meant for advanced conditions after the failing of chemotherapy attempts. 

For breast cancer, Taxotere can be used in combination with Doxorubicin and Cyclophosphamide and is indicated for treatment of patients with node-positive breast cancer which is locally advanced or metastatic. 

In terms of non-small cell lung cancer, Taxotere can be utilized exclusively as a single agent meant for patients with locally advanced or metastatic non-small cell lung cancer. Additionally, the drug can be used in combination with Cisplatin for those patients who have yet to seek chemotherapy. Combining with Cisplatin can also work in the treatment of advanced gastric adenocarcinoma with the addition of Fluorouracil. The combination of Cisplating and Fluorouracil can also be utilized in the treatment of head and neck cancer. For those suffering from prostate cancer, Taxotere can be used in combination with Prednisone. 

The drug must be administered in medical facilities equipped to handle possible complications that could derive from treatment. Typically done in a treatment plan, dosages are usually administered over one hour every three weeks. Treatment with Taxotere and dosage differs with each condition being treated. Consult with your doctor or health care professional to learn and understood your particular treatment plan and schedule.